No abstract

No abstract

Cycas pectinata Buch.-Ham. is commonly used in folk medicine against various disorders. The present study investigated the antidepressant and cytotoxicity activity of methanol extract of C. pectinata (MECP) along with quantitative phytochemical analysis by GC-MS method. Here, the GC-MS study of MECP presented 41 compounds, among which most were fatty acids, esters, terpenoids and oximes. The antidepressant activity was assessed by the forced swimming test (FST) and tail suspension test (TST) models. In contrast, MECP (200 and 400 mg/kg) exhibited a significant and dose-dependent manner reduction in immobility comparable with fluoxetine (10 mg/kg) and phenelzine (20 mg/kg). MECP showed a weak toxicity level in the brine shrimp lethality bioassay (ED50: 358.65 µg/mL) comparable to the standard drug vincristine sulfate (ED50: 2.39 µg/mL). Three compounds from the GC-MS study were subjected to density functional theory (DFT) calculations, where only cyclopentadecanone oxime showed positive and negative active binding sites. Cyclopentadecanone oxime also showed a good binding interaction in suppressing depression disorders by blocking monoamine oxidase and serotonin receptors with better pharmacokinetic and toxicological properties. Overall, the MECP exhibited a significant antidepressant activity with moderate toxicity, which required further advance studies to identify the mechanism.

Lepidagathis hyalina Nees is used locally in Ayurvedic medicine to treat coughs and cardiovascular diseases. This study explored its pharmacological potential through in vivo and in vitro approaches for the metabolites extracted (methanolic) from the stems of L. hyalina. A qualitative phytochemical analysis revealed the presence of numerous secondary metabolites. The methanol extract of L. hyalina stems (MELHS) showed a strong antioxidative activity in the 1,1-diphenyl-2-picrylhydrazyl (DPPH) and reducing power assays, and in the quantitative (phenolic and flavonoid) assay. Clot lysis and brine shrimp lethality bioassays were applied to investigate the thrombolytic and cytotoxic activities, respectively. MELHS exhibited an expressive percentage of clot lysis (33.98%) with a moderately toxic (115.11 μg/mL) effect. The in vivo anxiolytic activity was studied by an elevated plus maze test, whereas the antidepressant activity was examined by a tail suspension test and forced swimming test. During the anxiolytic evaluation, MELHS exhibited a significant dose-dependent reduction of anxiety, in which the 400 mg/kg dose of the extract showed 78.77 ± 4.42% time spent in the open arm in the elevated plus maze test. In addition, MELHS demonstrated dose-dependent and significant activities in the tail suspension test and forced swimming test, whereas the 400 mg/kg dose of the extract showed 87.67 ± 6.40% and 83.33 ± 6.39% inhibition of immobile time, respectively. Therefore, the current study suggests that L. hyalina could be a potential source of anti-oxidative, cytotoxic, thrombolytic, anxiolytic, and antidepressant agents. Further study is needed to determine the mechanism behind the bioactivities.

No abstract

No abstract

Over the past few decades, the synthesis and potential applications of nanocatalysts have received great attention from the scientific community. Many well-established methods are extensively utilized for the synthesis of nanocatalysts. However, most conventional physical and chemical methods have some drawbacks, such as the toxicity of precursor materials, the requirement of high-temperature environments, and the high cost of synthesis, which ultimately hinder their fruitful applications in various fields. Bioinspired synthesis is eco-friendly, cost-effective, and requires a low energy/temperature ambient. Various microorganisms such as bacteria, fungi, and algae are used as nano-factories and can provide a novel method for the synthesis of different types of nanocatalysts. The synthesized nanocatalysts can be further utilized in various applications such as the removal of heavy metals, treatment of industrial effluents, fabrication of materials with unique properties, biomedical, and biosensors. This review focuses on the biogenic synthesis of nanocatalysts from various green sources that have been adopted in the past two decades, and their potential applications in different areas. This review is expected to provide a valuable guideline for the biogenic synthesis of nanocatalysts and their concomitant applications in various fields.

Nanotechnology recently emerged among the most exciting science-related innovations. Nanotechnology-produced metal nanoparticles got a lot of attention. This is emerging as a rapidly developing field due to its effective applications that targeted the manufacturing of new materials at the nanoscale level. There is considerable interest in the application of nanomaterials in many areas of industry including agrifood and biomedical products. In the agrifood area, nanomaterials have benefits in diverse areas which include fertilizers, herbicides, pesticides, sensors, and quality stimulants, among other food processing, food packaging, and nutraceuticals to improve nutritional value. These applications in agriculture result in enhanced quality and crop yield, reduction in pollution caused by various chemicals, etc. In the pharmaceutical area, nanomaterials are claimed to ameliorate drug safety and efficacy, as well as bioavailability. They are utilized for targeting various drugs to a specific location in the body. However, there are also concerns that some nanoparticles may have adverse effects on human health. These include titanium dioxide, copper oxides, and other nanomaterials which lead to liver damage, skin damage, lung damage, and various other human health-related problems. This review is aimed at presenting a briefing on the state of the art in the application of nanotechnology in food and human nutrition and drug administration, consumer attitudes, and their challenges and opportunities with future perspectives.